NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for COX-2 Inhibitors


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
2009 NOV 23 ... pain patients get inadequate relief. Current treatments consist of NSAIDs, selective Cox-2 inhibitors, opioids and other analgesics that are dosed daily and have various tolerability and ...
Subject: Chronic Pain
Price: $3.00
*
New findings from Hokkaido University in the area of renal cell carcinoma therapy described
2009 NOV 23 ... OX2 6DP, England. Keywords: Japan, Sapporo, Renal Cell Carcinoma Therapy, COX-2 Inhibitors, Clinical Oncology, Clinical Trial Research, Combination Therapy, Cyclooxygenase, Drugs, ...
Subject: Renal Cell Carcinoma Therapy
Price: $3.00
*
New findings from University of Wisconsin in the area of inflammation published
2009 NOV 23 ... Keywords: City:Madison, State:WI, Country:United States, Bladder Disorders, COX-2 Inhibitors, Comparative Physiology, Cyclooxygenase, Cyclophosphamide, Drugs, Enzymes, Inflammation, ...
Subject: Inflammation
Price: $3.00
*
New pharmacological research from University of Liege discussed
2009 NOV 23 ... DC 20036, USA. Keywords: City:Liege, Country:Belgium, Antiinflammatory, COX-2 Inhibitors, Cyclooxygenase, Enzymes, Inflammation, Medicinal Chemistry, NSAIDS, Pain Medicine, ...
Subject: Pharmacological
Price: $3.00
*
New squamous cell carcinoma data have been reported by A. Khafif and co-authors
2009 NOV 16 ... Inc., 111 River St., Hoboken, NJ 07030, USA. Keywords: Israel, Tel Aviv, COX-2 Inhibitors, Cyclooxygenase, Enzymes, Head and Neck Cancer, Head and Neck Carcinoma, Head and Neck ...
Subject: Squamous Cell Carcinoma
Price: $3.00
*
New stem cell research data have been reported by researchers at Chinese Academy of Medical Sciences
2009 NOV 23 ... c release and caspase-3 activity. Aspirin initially caused a time-dependent decrease in COX-2 expression but subsequently, and unexpectedly, elevated the latter. Stimulation of COX-2 ... activation. Stimulating the Wnt/beta-catenin pathway by both Wnt 3a and GSK-3beta inhibitors (LiCl and SB 216763), blocked aspirin-induced apoptosis and protected mitochondrial ...
Subject: Stem Cell Research
Price: $3.00
*
New ulcer study findings reported from Kanazawa University
2009 NOV 16 ... Philadelphia, PA 19106-4404, USA. Keywords: Japan, Kanazawa, Asbestosis, COX-2 Inhibitors, Carcinogenesis, Colon Cancer, Colon Carcinoma, Cyclooxygenase, Enzymes, ...
Subject: Ulcer
Price: $3.00
*
PanGenetics Announces Acquisition by Abbott of PG110 anti-NGF Antibody to Treat Chronic Pain
2009 NOV 23 ... pain patients get inadequate relief. Current treatments consist of NSAIDs, selective Cox-2 inhibitors, opioids, and other analgesics that are dosed daily and have various tolerability and ...
Subject: PanGenetics
Price: $3.00
*
Recent studies from Kansas State University add new data to inflammation
2009 NOV 23 ... Country:United States, Autoimmune Disease, Autoimmune Disorder, Blood Transfusion, COX-2 Inhibitors, Gastroenterology, Immunology, Inflammation, Ischemia, Leukocyte Biology, Medical ...
Subject: Inflammation
Price: $3.00
*
Reports outline inflammation study findings from E.L. Barry and colleagues
2009 NOV 23 ... PA 19106-4404, USA. Keywords: Country:Lebanon, Adenoma, Aspirin, COX-2 Inhibitors, Cancer Epidemiology, Clinical Trial Research, Colon Cancer, Colon Carcinoma, ...
Subject: Inflammation
Price: $3.00
*
Research by M.S. Duh and colleagues in gastrointestinal reflux disease provides new insights
2009 NOV 16 ... 08536, USA. Keywords: United States, Boston, Acid Reflux, Antiinflammatory, COX-2 Inhibitors, Clinical Trial Research, Cyclooxygenase, Enzymes, Gastroenterology, Gastroesophageal ...
Subject: Gastrointestinal Reflux Disease
Price: $3.00
*
Research from United Arab Emirates University in life sciences provides new insights
2009 NOV 23 ... variety of organophosphorus compounds (OPCs). However, oximes themselves are also AChE inhibitors, albeit at higher concentrations, which is a major cause of their toxicity and may be a ...
Subject: Life Sciences
View Free
Daily News
Article
Research on Alzheimer disease reported by scientists at University of Washington
2009 NOV 16 ... toxicity in a prevention trial have shifted focus away from these cyclooxygenase (COX) inhibitors to seek additional therapeutic targets in the prostaglandin pathway. Previously, the ...
Subject: Alzheimer Disease
Price: $3.00
*
Research on ulcer risk factors discussed by scientists at Tohoku University
2009 NOV 16 ... 02148, USA. Keywords: Japan, Sendai, Ulcer Risk Factors, Blood Transfusion, COX-2 Inhibitors, Clinical Trial Research, Cyclooxygenase, Dermatology, Diagnosis, Diagnostics, Drugs, ...
Subject: Ulcer Risk Factors
Price: $3.00
*
Research results from H. Shimpo and colleagues update understanding of osteoarthritis
2009 NOV 16 ... of mitogen-activated protein kinases. IL-1 beta markedly enhanced the expression of COX-2 and microsomal prostaglandin E synthase-1 (mPGES-1) at both the mRNA and protein levels. ... the second passage were cultured with or without IL-1 beta, dexamethasone (DEX), or COX inhibitors such as NS-398, meloxicam, and indomethacin. Reverse transcription-polymerase chain ...
Subject: Osteoarthritis
Price: $3.00
*
Scientists at Cardiff University describe research in arthritis
2009 NOV 16 ... 17, D-69121 Heidelberg, Germany. Keywords: Wales, Arthritis, COX-2 Inhibitors, Cyclooxygenase, Enzymes, Pain Medicine, Cardiff University. This article ...
Subject: Arthritis
Price: $3.00
*
Studies from University of California yield new data on squamous cell carcinoma
2009 NOV 16 ... PA 19106-4404, USA. Keywords: United States, Los Angeles, Biotechnology, COX-2 Inhibitors, Cyclooxygenase, Cytokines, Enzymes, Experimental Design, Head and Neck Cancer, Head and ...
Subject: Squamous Cell Carcinoma
Price: $3.00
*
Study data from University of Frankfurt provide new insights into cancer
2009 NOV 16 ... St., New York, NY 10013, USA. Keywords: Germany, Frankfurt, Apoptosis, COX-2 Inhibitors, Celecoxib, Chromatography, Colon Cancer, Colon Carcinoma, Colorectal, Cyclooxygenase, ...
Subject: Cancer
Price: $3.00
*
Study data from Vanderbilt University, Medical Department provide new insights into radiopharmaceuticals
2009 NOV 17 ... Imaging Agent, Indomethacin, Pharmaceuticals, Drugs, Therapy, Treatment, Pain Medicine, COX-2 Inhibitors, Radiopharmaceuticals, Vanderbilt University, Medical Department. This ...
Subject: Radiopharmaceuticals
Price: $3.00
*
Study results from University of Hyderabad, Department of Animal Sciences in the area of epidermal cancer therapy published
2009 NOV 16 ... USA. Keywords: India, Hyderabad, Epidermal Cancer Therapy, Arthritis, COX-2 Inhibitors, Celecoxib, Cyclooxygenase, Drugs, Enzymes, Epidermal Cancer, Epidermal Carcinoma, ...
Subject: Epidermal Cancer Therapy
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login